Výsledky vyhledávání - "Michelle Padilla"

Efecto residual de Bacillus thuringiensis var israelensis en el control de Aedes aegypti en Honduras

Autor: Brayan J. Bennett, Ammi Bustillo Ponce, Nestor J. Yanes, Xenia I. Paz, Brian M. Erazo, Jairo García, Francia Ponce Guevara, Juan C. Amador, Bayron López, Michelle Padilla

Publikováno v: Innovare: Revista de ciencia y tecnología. 9:139-147

Introducción: El Aedes aegypti es el principal vector de transmisión del dengue, el chikungunya y el Zika. Honduras presenta una gran carga de morbilidad secundaria a estas arbovirosis. La bacteria de suelo Bacillus thuringiensis var israelensis (B

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae9e37a32eb594fa35d7eb212c970422
https://doi.org/10.5377/innovare.v9i3.10647

Zobrazit plný text záznamu

Phase II study of the combination of daratumumab, ixazomib, pomalidomide, and dexamethasone as salvage therapy in relapsed/refractory multiple myeloma: Stage 2 interim results

Autor: Anupama Deepa Kumar, Michelle Padilla, Lin Liu, Minya Pu, Emily Pittman, Dimitrios Tzachanis, Sarah Marie Larson, Nina Shah, Carolyn M. Mulroney, Edward David Ball, Aaron Seth Rosenberg, Caitlin Costello

Publikováno v: Journal of Clinical Oncology. 40:8041-8041

8041 Background: The combination of daratumumab (Dara), pomalidomide (POM), and dexamethasone (dex) (DPd) has previously demonstrated deep and durable responses including high rates of minimal residual disease (MRD) negativity, in patients with relap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::97ff69351176534873541b6b5dfe6b64
https://doi.org/10.1200/jco.2022.40.16_suppl.8041

Zobrazit plný text záznamu

Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial

Autor: Diem Le, Teresa Ta, Erika Cavallone, Joseph Tuscano, Swetha Kambhampati, Charalambos Andreadis, Matthew J. Wieduwilt, Michelle Padilla, Weiyun Z. Ai, Jesika Reiner, Miguel Castillo, Erika Crawford, Lawrence D. Kaplan, Bita Fakhri, Akshay Sudhindra, Michelle Martinelli, Charlie Aoun

Publikováno v: Clinical lymphoma, myelomaleukemia. 21(3)

Introduction We designed a multicenter, phase Ib dose-escalation trial of carfilzomib with bendamustine and rituximab in patients with relapsed/refractory non-Hodgkin lymphoma ( NCT02187133 ) in order to improve the response rates of this difficult-t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::230b02c8d73a5c8b17d734849db3722e
https://pubmed.ncbi.nlm.nih.gov/33478921

Zobrazit plný text záznamu

Pobreza, turismo y crecimiento económico en México, Chile y España, 2003 - 2016: enfoque econométrico

Autor: Andrea Michelle Padilla Martínez

Publikováno v: Universidad Michoacana de San Nicolás de Hidalgo
UMSNH
Repositorio Institucional de la Universidad Michoacana de San Nicolás de Hidalgo

Instituto de Investigaciones Económicas y Empresariales. Ciencias en Negocios Internacionales This paper examines the relationship between poverty, tourism and economic growth in 3 countries: Mexico, Chile and Spain. The data was obteined from the W

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::a6905829f0b56e78f669735bcedff87c
http://bibliotecavirtual.dgb.umich.mx:8083/xmlui/handle/DGB_UMICH/2670

Zobrazit plný text záznamu

A Randomized Phase II Trial Comparing a Calcineurin Inhibitor-Free Graft-Versus-Host Disease Prophylaxis Regimen with Post-Transplantation Cyclophosphamide and Abatacept to Standard of Care

Autor: Dimitrios Tzachanis, Carolyn Mulroney, James K. Mangan, Jodi Garrett, Michelle Padilla, Caitlin Costello, Peggy Breslin, Kimberly McConnell, Divya Koura, Edward D. Ball, Aaron M. Goodman, Joseph Maroge

Publikováno v: Blood. 138:1816-1816

Background: Graft versus host disease (GVHD) is one the major causes of mortality and morbidity after an allogeneic stem cell transplantation. We hypothesized that we can induce post-transplant tolerance by using the combination of post-transplant cy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c4101b3cca9b18314064838a98957f3d
https://doi.org/10.1182/blood-2021-145824

Zobrazit plný text záznamu

Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone As Salvage Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Safety Run-in Analysis

Autor: Carolyn Mulroney, Edward D. Ball, Caitlin Costello, Michelle Padilla

Publikováno v: Blood. 134:3117-3117

Background: Triplet combination strategies have widely been accepted as the standard of care for the management of multiple myeloma due to improved outcomes as compared to doublets. The combination of daratumumab, pomalidomide and dexamethasone (DPd)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7acd0e684a8805e0d92658860269793c
https://doi.org/10.1182/blood-2019-123506

Zobrazit plný text záznamu

A Phase 1b Dose Escalation Trial of Carfilzomib in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Autor: Matthew J. Wieduwilt, Weiyun Z. Ai, Teresa Ta, Bita Fakhri, Erika Crawford, Lawrence D. Kaplan, Swetha Kambhampati, Diem Le, Michelle Padilla, Charalambos Andreadis, Jimmy Hwang, Joseph Tuscano, Charlie Aoun, Akshay Sudhindra, Jesika Reiner, Michelle Martinelli

Publikováno v: Blood. 134:2828-2828

Background Despite advances in therapy, relapsed or refractory (RR) non-Hodgkin lymphoma (NHL) remains a major treatment challenge. Preclinical data support the activity of proteasome inhibitors against lymphoma through multiple mechanisms including

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::08a9c70cca2e4c0e41befc395a6d1e0c
https://doi.org/10.1182/blood-2019-123279

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání